Skip to content

Questionnaires and Cognitive Assessments Following Mammography

Symptom Tracking in Women Following Mammography

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03412370
Enrollment
6
Registered
2018-01-26
Start date
2017-07-27
Completion date
2017-09-21
Last updated
2019-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Status Unknown

Brief summary

This pilot research trial studies how well questionnaires and cognitive assessments work in tracking patient symptoms following mammography. Gathering information over time through questionnaires and cognitive tests about symptoms patients may experience after a mammogram may help doctors understand the cause of these symptoms.

Detailed description

PRIMARY OBJECTIVES: I. To determine the feasibility of Internet-based cognitive assessments as preliminary data prior to larger clinical trial. OUTLINE: Patients complete questionnaires and cognitive assessments over 45-60 minutes within 3 weeks following mammography and at about 3 months in patients for whom biopsy is not required, before biopsy and at about 3 months in patients for whom biopsy is required, and at 4-6 weeks after first chemotherapy infusion in patients receiving chemotherapy.

Interventions

OTHERCognitive Assessment

Complete cognitive assessments

OTHERQuestionnaire Administration

Complete questionnaires

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
University of Southern California
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Mammography Breast Imaging Reporting and Data System (BI-RAD) 4-5; or BI-RAD 1-2 * Fluent in English * Access to Internet * Ability to understand and the willingness to sign a written informed consent

Exclusion criteria

* Prior abnormal mammography * Prior cancer diagnosis * Prior treatment with chemotherapy

Design outcomes

Primary

MeasureTime frameDescription
Number of patients invited who agree to participateUp to 2 yearsNumber of patients invited will be reported.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026